ZIVO Bioscience, Inc. (ZIVO)
OTCMKTS · Delayed Price · Currency is USD
8.36
-1.74 (-17.18%)
Feb 11, 2026, 12:32 PM EST
ZIVO Bioscience Market Cap
ZIVO Bioscience has a market cap or net worth of $39.28 million as of February 13, 2026. Its market cap has decreased by -16.64% in one year.
Market Cap
39.28M
Enterprise Value
40.04M
Revenue
209.03K
Ranking
n/a
PE Ratio
n/a
Stock Price
$8.36
Market Cap Chart
Since October 30, 2003, ZIVO Bioscience's market cap has increased from 2.41M to 39.28M, an increase of 1,527.60%. That is a compound annual growth rate of 13.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 39.28M | 14.61% |
| Dec 31, 2025 | 34.27M | -55.05% |
| Dec 31, 2024 | 76.25M | 3,046.50% |
| Dec 29, 2023 | 2.42M | -89.71% |
| Dec 30, 2022 | 23.55M | -12.89% |
| Dec 31, 2021 | 27.03M | -56.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |
| Vicapsys Life Sciences | 48.56M |
| Cell Source | 41.50M |
| Arch Biopartners | 38.73M |
| Harvard Apparatus Regenerative Technology | 31.65M |
| Oncotelic Therapeutics | 28.70M |
| Finch Therapeutics Group | 22.08M |